Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the U.S. Food and Drug Administration (FDA) has accepted Sangamo’s request for a rolling submission and ...

James MacCleary, MP has written to the Chief Executive of Southern Water demanding urgent assurances for his constituents ...